iBio, Inc. (IBIO)
NCM · Common · CUSIP 451033609
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IBIO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
451033609 (prev. 45107K102 )
Market Cap
Small Cap
Business: iBio, Inc., a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using their iBioLaunch platform. The iBioLaunch platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. They use proprietary, transient gene expression in unmodified green plants instead of materials such as chicken eggs, mammalian and insect cells, transgenic plants, and human blood plasma required by other systems, to produce important biologic pharmaceuticals.

Company Contact

CEO
Martin B. Brenner
CFO
Felipe Duran
Headquarters
11750 Sorrento Valley Road, Suite 200, San Diego, CA92121
Phone
979-446-0027
Investor Relations
Stephen Kilmer · 646-274-3580 · skilmer@ibioinc.com
General Email
ir@ibioinc.com
SEC EDGAR Filings
View filings »